Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
GCMS and LCMS data of exometabolome of parental and Osimertinib-resistant EGFR-mutant NSCLC
GCMS and LCMS data of exometabolome of parental and Osimertinib-resistant EGFR-mutant NSCLC
Fuente:
Zenodo
Saved in:
Bibliographic Details
Main Author:
Bramanti, Emilia
Format:
Recurso digital
Published:
Zenodo
2025
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
Possible new mechanisms of primary drug resistance in NSCLC with EGFR mutation treated with Osimertinib
by: Lujing Shao, et al.
Published: (2025)
Sacituzumab tirumotecan improved survival for patients with EGFR TKI–resistant, EGFR‐mutant advanced NSCLC
by: Leah Lawrence
Published: (2026)
More treatment options emerge for EGFR ‐mutant NSCLC
by: Leah Lawrence
Published: (2026)
Clinical Management in NSCLC Patients With EGFR Mutation After Osimertinib Progression With Unknown Resistance Mechanisms
by: Xin Liao, et al.
Published: (2024)
Reply to “High Pharmacokinetic Variability and Unrecognized Limitations in First‐Line Osimertinib Plus Chemotherapy for EGFR ‐Mutated NSCLC ”
by: Azar Shahraz, et al.
Published: (2025)
